Literature DB >> 15582721

Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development.

Nadja Herbach1, Burkhard Goeke, Marlon Schneider, Walter Hermanns, Eckhard Wolf, Ruediger Wanke.   

Abstract

The expression of a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPRdn) under the control of the rat pro-insulin gene promoter induces severe diabetes mellitus in transgenic mice. This study aims to gain further insight into the effect of the expression of a dominant negative GIPR on glucose homeostasis and postnatal development of the endocrine pancreas. The diabetic phenotype of GIPRdn transgenic animals was first observed between 14 and 21 days of age (urine glucose>1000 mg/dl). After onset of diabetes, serum glucose was significantly higher and insulin values were significantly lower in GIPRdn transgenic mice vs. non-transgenic littermate controls. Morphometric studies of pancreatic islets and their endocrine cell types were carried out at 10, 30 and 90 days of age. The total islet and total beta-cell volume of transgenic mice was severely reduced as compared to control mice, irrespective of the age at sampling (p<0.05). The total volume of isolated insulin positive cells that were not contained within established islets was significantly reduced in transgenic mice, indicating disturbed islet neogenesis. These findings demonstrate in vivo evidence that intact signaling of G-protein coupled receptors is involved in postnatal islet and beta-cell development and neogenesis of the pancreatic islets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582721     DOI: 10.1016/j.regpep.2004.08.021

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  17 in total

Review 1.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

Review 2.  A synopsis of factors regulating beta cell development and beta cell mass.

Authors:  Krishna Prasadan; Chiyo Shiota; Xiao Xiangwei; David Ricks; Joseph Fusco; George Gittes
Journal:  Cell Mol Life Sci       Date:  2016-04-22       Impact factor: 9.261

Review 3.  [Pathogenesis of diabetes mellitus and diabetic complications. Studies on diabetic mouse models].

Authors:  N Herbach
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 4.  New functional aspects of the extracellular calcium-sensing receptor.

Authors:  Hakan R Toka
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

5.  Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice.

Authors:  Tsuyoshi Yanagimachi; Yukihiro Fujita; Yasutaka Takeda; Jun Honjo; Kuralay K Atageldiyeva; Yumi Takiyama; Atsuko Abiko; Yuichi Makino; Timothy J Kieffer; Masakazu Haneda
Journal:  Diabetologia       Date:  2015-12-22       Impact factor: 10.122

Review 6.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

7.  Early insulin therapy prevents beta cell loss in a mouse model for permanent neonatal diabetes (Munich Ins2(C95S)).

Authors:  S Kautz; L van Bürck; M Schuster; E Wolf; R Wanke; N Herbach
Journal:  Diabetologia       Date:  2011-11-18       Impact factor: 10.122

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

9.  Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.

Authors:  Simone Renner; Christiane Fehlings; Nadja Herbach; Andreas Hofmann; Dagmar C von Waldthausen; Barbara Kessler; Karin Ulrichs; Irina Chodnevskaja; Vasiliy Moskalenko; Werner Amselgruber; Burkhard Göke; Alexander Pfeifer; Rüdiger Wanke; Eckhard Wolf
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

Review 10.  Genetically engineered pig models for diabetes research.

Authors:  Eckhard Wolf; Christina Braun-Reichhart; Elisabeth Streckel; Simone Renner
Journal:  Transgenic Res       Date:  2013-09-25       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.